At 550mil AUD, Viralytic is dirt cheap acquisition for Merck.
They probably can't afford to bid on SPL anytime soon, SPL's vivagel (including recurrent treatment) alone will worth north of $1.52. Any offer will have to be in excess of 1B to get any dendrimer tech transfer, don't forget that once a bid is made public by 1 big pharma, more bidder will emerge. 170% north of today's price is far from compelling.
SPL business model and line up resemble like an early stage CSL, which now as we know has a 71B MC.
- Forums
- ASX - By Stock
- SPL
- Viralytics gobbled up.....Why not Starpharma
Viralytics gobbled up.....Why not Starpharma, page-12
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
-0.002(2.11%) |
Mkt cap ! $38.35M |
Open | High | Low | Value | Volume |
9.5¢ | 9.5¢ | 9.3¢ | $48.64K | 512.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 153365 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 153365 | 0.093 |
1 | 60000 | 0.092 |
1 | 5000 | 0.090 |
1 | 50000 | 0.089 |
2 | 147200 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 65000 | 1 |
0.099 | 56700 | 2 |
0.100 | 111205 | 3 |
0.105 | 146531 | 5 |
0.110 | 43099 | 6 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |